Navigation Links
Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
Date:3/15/2011

treat solid tumors. More information is available at www.oncosec.com.

About Inovio Pharmaceuticals, Inc.Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include three separate programs in Phase II clinical studies, including VGX-3100 for treating cervical dysplasia and cancer. Other Inovio clinical programs include those for avian flu (preventive) and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be succ
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
8. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
9. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced the ... Global Forecasts to 2019" report to their offering. ... estimated to grow expected to reach $9.37 billion by ... 2019. Factors such as growing ... increasing privatization in the healthcare sector, and rising adoption ...
(Date:7/28/2015)... 28, 2015  PD-Rx Pharmaceuticals, Inc., a publicly ... has partnered with Dobson Technologies, a fully-integrated outsourced ... (IaaS) product. PD-Rx is an Application ... United States.  Using Dobson Technologies, IaaS solution will ... continuity, ensure regulatory compliance, and reduce operating expenses.  ...
(Date:7/28/2015)... , July 28, 2015  For many medical ... researchers, physicians and other inventors can be a constant ... is difficult, and successes are rare. A ... to change that. Medical Device Investments (MDI) ... from universities, hospitals and physicians. MDI develops, manufactures and ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2PD-Rx Partners With Dobson Technologies 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
... and TARRYTOWN, N.Y., Nov. 10, 2011 Sanofi ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ... Phase 2 study program in which patients with ... REGN727/SAR236553. REGN727/SAR236553 is a novel, high-affinity, ...
... NASHVILLE, Tenn., Nov. 9, 2011 Revenue ... Non-GAAP Adjusted EBITDA of $76.7 million, increased 15.3% over third ... of healthcare revenue and payment cycle management and clinical information ... ended September 30, 2011, as summarized below: (In millions, except ...
Cached Medicine Technology:Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 2Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 3Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 4Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 5Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 6Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 7Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 8Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 9Emdeon Reports Third Quarter 2011 Results 2Emdeon Reports Third Quarter 2011 Results 3Emdeon Reports Third Quarter 2011 Results 4Emdeon Reports Third Quarter 2011 Results 5Emdeon Reports Third Quarter 2011 Results 6Emdeon Reports Third Quarter 2011 Results 7Emdeon Reports Third Quarter 2011 Results 8Emdeon Reports Third Quarter 2011 Results 9Emdeon Reports Third Quarter 2011 Results 10Emdeon Reports Third Quarter 2011 Results 11Emdeon Reports Third Quarter 2011 Results 12Emdeon Reports Third Quarter 2011 Results 13
(Date:7/28/2015)... ... July 28, 2015 , ... A skin cancer screening ... national 2015 Power of A award for “helping to make the world a better ... Gold Award winner by the American Society of Association Executives. Power of A recognizes ...
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique women’s wellness and lifestyle ... and mindful living practices to the next level, announced today an influential line-up of ... as keynote. Global Girls, an Orange County based non-profit that works locally and ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... October this year, as volunteers celebrate the 14th year of raising money for ... Lawrence in downtown Savannah for this year’s main concert Saturday, Oct. 3. , ...
(Date:7/28/2015)... ... ... Dr. Edward Buckingham and Buckingham Center for Facial Plastic Surgery, is ... to Austin from Philadelphia, Dr. Roy will be completing his Fellowship in facial plastic ... by the American Academy of Facial Plastic and Reconstructive Surgery. , Since 1969, ...
(Date:7/28/2015)... Francisco, California (PRWEB) , ... July 28, 2015 , ... ... the results from a recent survey (1) examining consumers’ perspectives on digital ... June 17-24, 2015, covered topics such as innovations in digital health, level of trust ...
Breaking Medicine News(10 mins):Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5
... ... are located , ... (PRWEB) June 2, 2010 -- Beachhead Solutions Inc. announced today the first true PC ... (MSPs). For those organizations affected by the new laws requiring encryption of sensitive PC ...
... ... role in suppressing tumor growth, has been successfully demonstrated for the first time using ... the technique opens the door to effective new cell-targeted treatments for cancer. , ... (PRWeb UK) June 1, ...
... autonomy fades, tomorrow,s elderly will need to create non-traditional support ... This is the conclusion of Jacques Lgar, professor at the ... whom children are relatively rare and stable couples almost an ... Congress of the Humanities and Social Sciences, held this week ...
... , ... the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical ... CEO, is a finalist for the Ernst & Young Entrepreneur Of The Year 2010 ... ...
... too much supplemental calcium are on the rise, according ... the Journal of the American Society Nephrology ... syndrome is growing in large part because of widespread ... The milk-alkali syndrome arose in the early 1900s when ...
... June 1, 2010 By discovering how adult neural stem ... UC Irvine researchers have helped solve a puzzle in the ... where to go? Tom Lane and Kevin Carbajal of ... the answer with the body,s immune system. Their study ...
Cached Medicine News:Health News:PC Encryption Compliance Delivered Through The Cloud Now Available As Simple Monthly Service For Business 2Health News:PC Encryption Compliance Delivered Through The Cloud Now Available As Simple Monthly Service For Business 3Health News:New Technique Transforms iPS Cells into Natural Tumor Killers 2Health News:Aging baby boomers will have to innovate 2Health News:Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist 2Health News:Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist 3Health News:Calcium supplements: too much of a good thing? 2Health News:Immune system helps transplanted stem cells navigate in central nervous system 2
... of a Matching Card, three HRR symbol cards ... a child for subsequent HRR 4th Edition color ... test. For the youngest patients, the parents can ... the concept of matching and become familiar with ...
Magnetic Farnsworth D15 kit. Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... test from Richmond Products includes the four demonstration ... diagnostic series for a total of 24 plates. ... for easy and clean page selection. The test ... and a laminated copy of the score sheet. ...
Ishihara 14 plate color vision testing set. Suitable for screening purposes....
Medicine Products: